Titre : Épistaxis

Épistaxis : Questions médicales fréquentes

Termes MeSH sélectionnés :

Complement C4
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Épistaxis : Questions médicales les plus fréquentes", "headline": "Épistaxis : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Épistaxis : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-01", "dateModified": "2025-02-26", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Épistaxis" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Signes et symptômes respiratoires", "url": "https://questionsmedicales.fr/mesh/D012818", "about": { "@type": "MedicalCondition", "name": "Signes et symptômes respiratoires", "code": { "@type": "MedicalCode", "code": "D012818", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.852" } } }, "about": { "@type": "MedicalCondition", "name": "Épistaxis", "alternateName": "Epistaxis", "code": { "@type": "MedicalCode", "code": "D004844", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "David E Tunkel", "url": "https://questionsmedicales.fr/author/David%20E%20Tunkel", "affiliation": { "@type": "Organization", "name": "Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA." } }, { "@type": "Person", "name": "Sarah M Holdsworth", "url": "https://questionsmedicales.fr/author/Sarah%20M%20Holdsworth", "affiliation": { "@type": "Organization", "name": "Emory University Hospital, Atlanta, Georgia, USA." } }, { "@type": "Person", "name": "Jacqueline D Alikhaani", "url": "https://questionsmedicales.fr/author/Jacqueline%20D%20Alikhaani", "affiliation": { "@type": "Organization", "name": "Consumers United for Evidence-based Healthcare (CUE), Baltimore, Maryland, USA." } }, { "@type": "Person", "name": "Taskin M Monjur", "url": "https://questionsmedicales.fr/author/Taskin%20M%20Monjur", "affiliation": { "@type": "Organization", "name": "American Academy of Otolaryngology-Head and Neck Surgery Foundation, Alexandria, Virginia, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Plasma Complement 3 and Complement 4 Are Promising Biomarkers for Distinguishing NMOSD From MOGAD and Are Associated With the Blood-Brain-Barrier Disruption in NMOSD.", "datePublished": "2022-07-11", "url": "https://questionsmedicales.fr/article/35898513", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2022.853891" } }, { "@type": "ScholarlyArticle", "name": "Variations of C3 and C4 Before and During Pregnancy in Systemic Lupus Erythematosus: Association With Disease Flares and Obstetric Outcomes.", "datePublished": "2023-05-01", "url": "https://questionsmedicales.fr/article/37127323", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3899/jrheum.2022-1135" } }, { "@type": "ScholarlyArticle", "name": "HMGB1 cleavage by complement C1s and its potent anti-inflammatory product.", "datePublished": "2023-04-26", "url": "https://questionsmedicales.fr/article/37180096", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2023.1151731" } }, { "@type": "ScholarlyArticle", "name": "A complement C4-derived glycopeptide is a biomarker for PMM2-CDG.", "datePublished": "2024-04-08", "url": "https://questionsmedicales.fr/article/38587076", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1172/jci.insight.172509" } }, { "@type": "ScholarlyArticle", "name": "Analysis of the complement component C4 gene with schizophrenia subphenotypes.", "datePublished": "2024-07-30", "url": "https://questionsmedicales.fr/article/39084106", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.schres.2024.07.039" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "Signes et symptômes", "item": "https://questionsmedicales.fr/mesh/D012816" }, { "@type": "ListItem", "position": 4, "name": "Signes et symptômes respiratoires", "item": "https://questionsmedicales.fr/mesh/D012818" }, { "@type": "ListItem", "position": 5, "name": "Épistaxis", "item": "https://questionsmedicales.fr/mesh/D004844" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Épistaxis - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Épistaxis", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-05", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Épistaxis", "description": "Comment diagnostiquer une épistaxis ?\nQuels tests sont nécessaires pour l'épistaxis ?\nQuand consulter un spécialiste pour épistaxis ?\nQuels signes indiquent une épistaxis grave ?\nL'imagerie est-elle nécessaire pour l'épistaxis ?", "url": "https://questionsmedicales.fr/mesh/D004844?mesh_terms=Complement+C4&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Épistaxis", "description": "Quels sont les symptômes de l'épistaxis ?\nL'épistaxis peut-elle causer des douleurs ?\nPeut-on avoir des saignements bilatéraux ?\nY a-t-il des signes d'infection avec l'épistaxis ?\nL'épistaxis peut-elle être chronique ?", "url": "https://questionsmedicales.fr/mesh/D004844?mesh_terms=Complement+C4&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Épistaxis", "description": "Comment prévenir l'épistaxis ?\nLes allergies peuvent-elles causer l'épistaxis ?\nFaut-il éviter de se moucher fort ?\nLes médicaments anticoagulants augmentent-ils le risque ?\nComment maintenir l'humidité nasale ?", "url": "https://questionsmedicales.fr/mesh/D004844?mesh_terms=Complement+C4&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Épistaxis", "description": "Comment traiter une épistaxis légère ?\nQuels médicaments peuvent aider l'épistaxis ?\nQuand utiliser un cautérisateur pour l'épistaxis ?\nLes antibiotiques sont-ils nécessaires pour l'épistaxis ?\nQuelles interventions chirurgicales existent pour l'épistaxis ?", "url": "https://questionsmedicales.fr/mesh/D004844?mesh_terms=Complement+C4&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Épistaxis", "description": "Quelles complications peuvent survenir avec l'épistaxis ?\nL'épistaxis peut-elle entraîner une perte de sang importante ?\nPeut-on avoir des séquelles après une épistaxis ?\nL'épistaxis peut-elle causer des infections ?\nQuels sont les risques d'une épistaxis chronique ?", "url": "https://questionsmedicales.fr/mesh/D004844?mesh_terms=Complement+C4&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Épistaxis", "description": "Quels sont les facteurs de risque de l'épistaxis ?\nLe tabagisme augmente-t-il le risque d'épistaxis ?\nLes traumatismes nasaux sont-ils un facteur de risque ?\nLes infections respiratoires peuvent-elles causer l'épistaxis ?\nL'hypertension est-elle un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D004844?mesh_terms=Complement+C4&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une épistaxis ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen physique et l'historique médical du patient." } }, { "@type": "Question", "name": "Quels tests sont nécessaires pour l'épistaxis ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins peuvent être effectués pour évaluer la coagulation sanguine." } }, { "@type": "Question", "name": "Quand consulter un spécialiste pour épistaxis ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Consultez un ORL si les saignements sont fréquents ou sévères." } }, { "@type": "Question", "name": "Quels signes indiquent une épistaxis grave ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des saignements abondants, des vertiges ou une perte de conscience nécessitent une attention immédiate." } }, { "@type": "Question", "name": "L'imagerie est-elle nécessaire pour l'épistaxis ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie est rarement nécessaire, sauf en cas de suspicion de lésion sous-jacente." } }, { "@type": "Question", "name": "Quels sont les symptômes de l'épistaxis ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent un saignement nasal, parfois accompagné de douleur ou de congestion." } }, { "@type": "Question", "name": "L'épistaxis peut-elle causer des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'épistaxis peut être accompagnée de douleurs au nez ou de sensations de pression." } }, { "@type": "Question", "name": "Peut-on avoir des saignements bilatéraux ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'épistaxis peut survenir dans une ou les deux narines, selon la cause." } }, { "@type": "Question", "name": "Y a-t-il des signes d'infection avec l'épistaxis ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des signes d'infection peuvent inclure des écoulements purulents ou de la fièvre." } }, { "@type": "Question", "name": "L'épistaxis peut-elle être chronique ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines personnes peuvent souffrir d'épistaxis récurrente ou chronique." } }, { "@type": "Question", "name": "Comment prévenir l'épistaxis ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les irritants nasaux, hydratez-vous et utilisez un humidificateur d'air." } }, { "@type": "Question", "name": "Les allergies peuvent-elles causer l'épistaxis ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les allergies peuvent provoquer une inflammation et des saignements du nez." } }, { "@type": "Question", "name": "Faut-il éviter de se moucher fort ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, se moucher trop fort peut provoquer ou aggraver une épistaxis." } }, { "@type": "Question", "name": "Les médicaments anticoagulants augmentent-ils le risque ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les anticoagulants peuvent augmenter le risque d'épistaxis en affectant la coagulation." } }, { "@type": "Question", "name": "Comment maintenir l'humidité nasale ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Utilisez des sprays salins ou des gels pour garder les muqueuses nasales hydratées." } }, { "@type": "Question", "name": "Comment traiter une épistaxis légère ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Pour une épistaxis légère, il est conseillé de se pencher en avant et de pincer le nez." } }, { "@type": "Question", "name": "Quels médicaments peuvent aider l'épistaxis ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des décongestionnants ou des sprays nasaux peuvent être utilisés pour réduire l'inflammation." } }, { "@type": "Question", "name": "Quand utiliser un cautérisateur pour l'épistaxis ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Un cautérisateur est utilisé pour sceller les vaisseaux sanguins en cas de saignements persistants." } }, { "@type": "Question", "name": "Les antibiotiques sont-ils nécessaires pour l'épistaxis ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les antibiotiques ne sont pas généralement nécessaires, sauf en cas d'infection associée." } }, { "@type": "Question", "name": "Quelles interventions chirurgicales existent pour l'épistaxis ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des interventions comme l'embolisation des vaisseaux peuvent être nécessaires pour les cas graves." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec l'épistaxis ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'anémie, l'infection ou des problèmes respiratoires graves." } }, { "@type": "Question", "name": "L'épistaxis peut-elle entraîner une perte de sang importante ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une épistaxis sévère peut entraîner une perte de sang significative et nécessiter une intervention." } }, { "@type": "Question", "name": "Peut-on avoir des séquelles après une épistaxis ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des séquelles sont rares, mais des problèmes de coagulation peuvent persister." } }, { "@type": "Question", "name": "L'épistaxis peut-elle causer des infections ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des infections peuvent survenir si des bactéries pénètrent par les muqueuses endommagées." } }, { "@type": "Question", "name": "Quels sont les risques d'une épistaxis chronique ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "L'épistaxis chronique peut entraîner des complications comme l'anémie ou des troubles de la coagulation." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de l'épistaxis ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent la sécheresse de l'air, les allergies, et l'utilisation de médicaments anticoagulants." } }, { "@type": "Question", "name": "Le tabagisme augmente-t-il le risque d'épistaxis ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut irriter les muqueuses nasales et augmenter le risque de saignement." } }, { "@type": "Question", "name": "Les traumatismes nasaux sont-ils un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traumatismes au nez, comme les coups ou les chutes, augmentent le risque d'épistaxis." } }, { "@type": "Question", "name": "Les infections respiratoires peuvent-elles causer l'épistaxis ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections respiratoires peuvent provoquer une inflammation et des saignements du nez." } }, { "@type": "Question", "name": "L'hypertension est-elle un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'hypertension peut augmenter le risque d'épistaxis en exerçant une pression sur les vaisseaux sanguins." } } ] } ] }

Sources (1796 au total)

Plasma Complement 3 and Complement 4 Are Promising Biomarkers for Distinguishing NMOSD From MOGAD and Are Associated With the Blood-Brain-Barrier Disruption in NMOSD.

Neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody (MOG-IgG) associated disease (MOGAD) are autoimmune inflammatory demyelinating diseases of the central ... In this observational study, data from 73 aquaporin-4 antibodies (AQP4-IgG) positive NMOSD patients and 22 MOG-IgG positive MOGAD patients were collected retrospectively. Demographics, clinical charac... The ages of onset were later in the AQP4-IgG positive NMOSD group and females predominated, which differed from the MOGAD group, whose ages were younger and with a slight male preponderance. The AQP4-... During the acute phase of NMOSD and MOGAD, plasma C3 and C4 may become potential biomarkers for distinguishing the two diseases and reflecting the NMOSD BBB damage....

Variations of C3 and C4 Before and During Pregnancy in Systemic Lupus Erythematosus: Association With Disease Flares and Obstetric Outcomes.

To analyze complement level variations in systemic lupus erythematosus (SLE) pregnancies, focusing on disease flares and obstetric complications.... SLE pregnancies prospectively followed by multidisciplinary teams from 1987 to 2018 in 2 Italian rheumatology centers were retrospectively analyzed. As reference, pregnancy-modified ranges of normal l... Two hundred forty-six pregnancies in 172 patients with SLE were analyzed. Eighty-nine percent were live births. Thirty-five flares were recorded in 30 pregnancies (12.2%) and obstetric complications o... Low C4 at preconception was found to be an independent risk factor for SLE flare during pregnancy. Not only C3 and C4 levels but also their variations should be observed, as their failure to increase ...

Analysis of the complement component C4 gene with schizophrenia subphenotypes.

The complement component C4 gene has been identified as a strong marker for schizophrenia (SCZ) risk. The C4 gene has a complex genetic structure consisting of variable structural elements (C4A, C4B, ... A total of 613 patients with DSM-IV SCZ or schizoaffective disorder (SCZ-AFF) were recruited to investigate the relationship between C4 gene variants and clinical characteristics of SCZ (age of onset,... We observed associations between C4 and clinical characteristics of SCZ (age of onset, symptom severity, GAF) and found significant differences when males and females were examined separately.... Overall, our preliminary findings encourage future investigations of C4 in SCZ-related phenotypes, including antipsychotic response and side effects. The study sample was of moderate size; therefore, ...

Role of fluid-phase complement system regulation in the development of hepatitis C virus-associated glomerulonephritis.

It is not known why only some hepatitis C virus (HCV) infected patients develop glomerulonephritis (GN). Therefore, we investigated the role of soluble complement regulators in the development of HCV ... Patients with HCV associated GN who were admitted to our nephrology unit between July 2016 and July 2018 were recruited to the study (group 1). Two other age and sex matched groups were studied as con... Serum levels of complement 4 binding protein (C4BP) were significantly lower in group 1 (median 70 ng/ml) than in groups 2 (median 88.8 ng/ml) and 3 (median 82.8 ng/ml) with p value of 0.007. The mino... Low C4BP levels are associated with GN in HCV infected patients. In addition, rs800292 SNP in CFH protects against GN in patients with HCV....

The Role of Complement System's C3 and C4 Fractions in the Pathogenesis of Uveitis.

To study the role of the complement system's C3 and C4 fractions in the pathogenesis of different types of uveitis.... A prospective case-control study. 118 patients were enrolled. The control group comprised 60 patients who were otherwise healthy people undergoing cataract or pterygium surgery, whereas the uveitis pa... No statistically significant differences were found in the levels of the C3 and C4 fractions in the blood between the groups. However, a statistically significant difference was observed in the levels... Our findings are in line with our initial hypothesis, that the complement system's C3 and C4 fractions may have a role in the pathogenesis of uveitis....

Serum concentrations of complement C3 and C4 in dogs with idiopathic epilepsy.

High concentrations of complement factors are presented in serum of animal epilepsy models and human patients with epilepsy.... To determine whether complement dysregulation occurs in dogs with idiopathic epilepsy (IE).... The study included 49 dogs with IE subgrouped into treatment (n = 19), and nontreatment (n = 30), and 29 healthy dogs.... In this case-control study, the serum concentrations of the third (C3) and fourth (C4) components of the complement system were measured using a canine-specific ELISA kit.... Serum C3 and C4 concentrations were significantly higher in dogs with IE (C3, median; 4.901 [IQR; 3.915-6.673] mg/mL, P < .001; C4, 0.327 [0.134-0.557] mg/mL, P = .03) than in healthy control dogs (C3... Dysregulation of classical complement pathway was identified in IE dogs. Serum C3 and C4 concentrations could be diagnostic biomarkers for IE in dogs with higher seizure frequency....